Literature DB >> 20878082

Increased Cul1 expression promotes melanoma cell proliferation through regulating p27 expression.

Guangdi Chen1, Gang Li.   

Abstract

Cullin1 (Cul1) serves as a rigid scaffold in SCF (Skp1/Cullin/Rbx1/F-box protein) complex, the largest family of ubiquitin-protein E3 ligases, and aberrant expression of Cul1 is involved in dysfunction of SCF E3 ligases. Previously, we found that Cul1 expression is increased in early stages of melanoma. In the present study, we further investigated the role of Cul1 in melanoma development. Our results showed that knockdown of Cul1 inhibits melanoma cell growth while overexpression of Cul1 enhances cell proliferation through the control of cell cycle progression. We also found that Cul1 regulates melanoma cell growth and cell cycle progression through degradation of p27 by functional SCFSkp2 complex. This study elucidates the role of Cul1 in melanoma cell proliferation and improves our understanding of increased expression of Cul1 in early stages of melanoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878082     DOI: 10.3892/ijo_00000786

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  21 in total

Review 1.  Ring finger protein 146/Iduna is a poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase.

Authors:  Zhi-dong Zhou; Christine Hui-shan Chan; Zhi-cheng Xiao; Eng-king Tan
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

Review 2.  Role of E3 ubiquitin ligases in gastric cancer.

Authors:  Ya-Chao Hou; Jing-Yu Deng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  MEK inhibitor effective against proliferation in breast cancer cell.

Authors:  Yan Zhou; Hai-Yan Hu; Wei Meng; Ling Jiang; Xing Zhang; Jing-Jing Sha; Zhigang Lu; Yang Yao
Journal:  Tumour Biol       Date:  2014-06-18

4.  Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.

Authors:  Wen Liu; You Wang; Chuanling Zhang; Baoshan Huang; Jin Bai; Lijun Tian
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer.

Authors:  Weimin Wang; Yansu Chen; Jianliang Deng; Jianping Zhou; Xiancheng Gu; Yuehua Tang; Guoqiang Zhang; Yongfei Tan; Zhijun Ge; Yulin Huang; Shouyu Wang; Jianwei Zhou; Yan Zhou; Sujun Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-05       Impact factor: 4.553

6.  Aberrant expression pattern and location of cullin 1 are associated with the development of papillary carcinoma in thyroid and cyclin D1 expression.

Authors:  Sung-Im Do; Kyungeun Kim; Hyunjoo Lee; Hyun-Soo Kim; Tae Gu Do; Jisup Yun; Dong-Hoon Kim; Seoung Wan Chae; Yong Lai Park; Chan Heun Park; Jin Hee Sohn; Kyueng-Whan Min; Jung-Soo Pyo
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 7.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Authors:  Chuan-Ming Xie; Wenyi Wei; Yi Sun
Journal:  J Genet Genomics       Date:  2013-02-10       Impact factor: 4.275

8.  The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.

Authors:  Ji-Gen Ping; Fei Wang; Jin-Xian Pu; Ping-Fu Hou; Yan-Su Chen; Jin Bai; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2016-07-23

9.  Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.

Authors:  Ronan T Swords; Steven Coutre; Michael B Maris; Joshua F Zeidner; James M Foran; Jose Cruz; Harry P Erba; Jesus G Berdeja; Wayne Tam; Saran Vardhanabhuti; Iwona Pawlikowska-Dobler; Hélène M Faessel; Ajeeta B Dash; Farhad Sedarati; Bruce J Dezube; Douglas V Faller; Michael R Savona
Journal:  Blood       Date:  2018-01-18       Impact factor: 22.113

10.  Cullin-1 and -2 Protein Expression in Colorectal Cancer: Correlation with Clinicopathological Variables.

Authors:  Othon Michail; Demetrios Moris; Stamatios Theocharis; John Griniatsos
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.